Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AFNT-111 by Affini-T Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
AFNT-111 is under clinical development by Affini-T Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
AFNT-111 by Affini-T Therapeutics for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
AFNT-111 is under clinical development by Affini-T Therapeutics and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
AFNT-111 by Affini-T Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
AFNT-111 is under clinical development by Affini-T Therapeutics and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...